Lin Kenneth 4
4 · Anebulo Pharmaceuticals, Inc. · Filed Apr 7, 2025
Insider Transaction Report
Form 4
Lin Kenneth
Director
Transactions
- Award
Stock Option (right to buy)
2025-04-04+25,000→ 25,000 totalExercise: $1.02Exp: 2035-04-03→ Common Stock (25,000 underlying) - Award
Stock Option (right to buy)
2025-04-04+4,964→ 4,964 totalExercise: $1.02Exp: 2035-04-03→ Common Stock (4,964 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders.